Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:30 PM
Ignite Modification Date:
2025-12-24 @ 6:30 PM
NCT ID:
NCT02296957
Eligibility Criteria:
Inclusion criteria
* Patients hospitalized in one of the investigation centres
* Individuals (male and female) aged 65 years and above
* Patients prescribed an hypnosedative drug during the hospitalization (after the first 48 hours)
* Patients from whom a non-opposition of participation in the research is obtained
* Patients with no history of hypnosedative at the admission (and during the first 48 hours of hospitalization)
* Individuals not suffering from cognitive impairment suggested by a score of less than 24 on the Mini-Mental State Examination
* Patients returning home at discharge
* Patients reachable by phone
Exclusion criteria
* Patients who gave their opposition to participate in the study
* Patient with physical disability
* Patients suffering from severe depression with suicide risk or other severe psychopathologic conditions
* Individuals suffering from cognitive impairment suggested by a score of less than 24 on the Mini-Mental State Examination
* Patients suffering from metastatic/terminal cancer or undergoing parenteral treatment (cytotoxic or targeted therapy) for cancer or in palliative care program
* Patients with severe alcohol or drug dependence
* Patients unable to answer a questionnaire in French
* Patients unable to undergo the intervention
* Patients not available by phone at discharge
* Patients not returning home at discharge
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT02296957
Study Brief:
Protocol Section:
NCT02296957